ASSOCIATION OF GENERAL AND ABDOMINAL OBESITY WITH PLASMA VITAMIN D3 LEVELS IN YOUNG ADULTS

2019 ◽  
Vol 3 (5) ◽  
Author(s):  
Sandeep Soam Singh ◽  
Sonali Chaturvedi
Keyword(s):  
Vitamin D ◽  
Young Adults ◽  
Waist Circumference ◽  
Abdominal Obesity ◽  
Central Obesity ◽  
Reference Group ◽  
Plasma Vitamin ◽  
General Obesity ◽  
Vitamin D Levels ◽  
The Mean

Aim: To assess whether serum Vitamin D levels are associated with general and abdominal obesity in young adults. Materials & Methods: A total of 113 MBBS students of the same batch aged 17–21 years (59 boys and 54 girls) were included in this case-control study. Height and body weight were measured to calculate Body Mass Index (BMI) for General obesity and waist circumference was measured for central obesity. Plasma vitamin D levels were measured. Participants were grouped according to Asian criteria for BMI and abdominal circumference in normal and obese group. Results: Mean age of students, who participated in study, was 18.2± 0.95 years. In the general obesity group the mean plasma Vitamin D level was 18.77±13.31ng/ml and in its normal reference group(with normal BMI) the mean plasma Vitamin D level was 19.02±16.21ng/ml. In the central obesity group the mean plasma Vitamin D level for males was 21.10±13.30ng/ml and in females 13.52±10.5 ng/ml and in its normal reference group(with normal waist circumference) the mean plasma Vitamin D level in males was 20.16±11.89ng/ml and in females it was 12.66±9.40 ng/ml. Conclusion: Comparison between obese group and normal group revealed that general obesity and central obesity has no correlation with plasma Vitamin D levels. Plasma Vitamin D deficiency was prevalent even in apparently healthy young individuals and it is more common in females. Key words: Plasma Vitamin D, Obese, Asian criteria of BMI, MBBS students

scholarly journals Assessment of Obesity using Anthropometric Markers among University Students

2021 ◽  
Vol 9 (1) ◽  
pp. 211-221
Author(s):  
Astha Astha ◽  
Bindu Krishnan ◽  
Anup Kharde
Keyword(s):  
Young Adults ◽  
Waist Circumference ◽  
Abdominal Obesity ◽  
Central Obesity ◽  
Normal Weight ◽  
Asia Pacific ◽  
General Obesity ◽  
Height Ratio ◽  
Anthropometric Measures ◽  
High Positive Correlation

Over the past few decades there has been an increase in the central or abdominal obesity. Endothelial dysfunction, insulin resistance with metabolic syndrome and a higher cardiometabolic risk are directly linked to abdominal obesity. A better understanding of the epidemiology of obesity would provide insights to its mitigation. This cross sectional study was designed to identify Central obesity, General obesity and Normal Weight central obesity among young adults using the following surrogate markers Waist circumference (WC), Waist hip ratio (WHR), Waist height ratio (WtHR) and BMI. After due informed written consent, 300 young adults with equal representation of both sexes (150 each) studying MBBS, Dentistry and Physiotherapy stream in a private university were selected. Various anthropometric measures like weight, hip circumference and waist circumference and height were measured according to WHO STEPS instrument. BMI based on Asia- Pacific cut -off values was used to define general obesity. Central obesity was defined by a Waist Circumference of  80 cm in females and  90 cm in male’s .For waist to height ratio a value of  0.5 in both genders was used. For waist to hip ratio the cut off value used was 0.85 in females and 0.90 in males. An individual with normal weight according to BMI but having central obesity fits into Normal Weight Central obesity category. Average age of the participants was 20.6 1.31 years. General Obesity was more among males with 46% prevalence as compared to 25.33%among females. In contrast, the prevalence of central obesity was more among females. The prevalence of Normal weight central obesity was more among females, varying from 4% to 17% using different types of anthropometric measures for central obesity. A high positive correlation was observed between BMI with WC, WtHR and WHR. (p=0.0001) Current practice of taking only BMI into consideration for defining obesity in our country needs serious re-evaluation considering the increasing prevalence of abdominal obesity and its long term impact.

scholarly journals Prevalence of Vitamin D Deficiency in Treatment-Naïve Subjects with Chronic Pulmonary Aspergillosis

2020 ◽  
Vol 6 (4) ◽  
pp. 202
Author(s):  
Inderpaul Singh Sehgal ◽  
Sahajal Dhooria ◽  
Kuruswamy Thurai Prasad ◽  
Valliappan Muthu ◽  
Naresh Sachdeva ◽  
...  
Keyword(s):  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Immunological Response ◽  
Plasma Vitamin ◽  
Healthy Controls ◽  
Pulmonary Aspergillosis ◽  
Vitamin D Levels ◽  
Treatment Naïve ◽  
Chronic Pulmonary Aspergillosis ◽  
The Mean

The association of vitamin D deficiency in the pathogenesis of invasive and allergic pulmonary aspergillosis is known. Whether vitamin D deficiency is prevalent in chronic pulmonary aspergillosis (CPA) remains unknown. We evaluated the prevalence of vitamin D deficiency in subjects with CPA. We compared the clinicoradiological features, microbiology, the immunological response, and the severity of CPA in those with or without vitamin D deficiency. We measured plasma vitamin D levels in 230 consecutive treatment-naïve subjects with CPA and 78 controls (28 with prior tuberculosis (TB); 50 healthy controls). We defined vitamin D deficiency as 25(OH)D3 level <20 ng/mL. The mean (95% confidence intervals (CI)) levels of plasma vitamin D levels were 19.5 (17.6–21.4), 18.6 (13.9–23.3), and 15.3 (12.6–17.9) ng/mL in subjects with CPA, diseased controls, and healthy controls, respectively; and the levels were not different between the groups. The prevalence of vitamin D deficiency in subjects with CPA was 65% (n = 150) and was also not different between healthy (70%) or diseased (61%) controls. We did not find any difference in the clinicoradiological features, microbiology, immunological response, and severity of CPA between vitamin D sufficient and deficient groups. The prevalence of vitamin D deficiency is high in subjects with CPA, albeit similar to controls. Vitamin D deficiency does not affect the disease severity in subjects with CPA.

Vitamin D levels are not associated with non-alcoholic fatty liver disease severity in a Brazilian population

2020 ◽  
pp. 1-8
Author(s):  
Jeniffer Danielle M. Dutra ◽  
Quelson Coelho Lisboa ◽  
Silvia Marinho Ferolla ◽  
Carolina Martinelli M. L. Carvalho ◽  
Camila Costa M. Mendes ◽  
...  
Keyword(s):  
Vitamin D ◽  
Liver Disease ◽  
Fatty Liver ◽  
Disease Severity ◽  
Fatty Liver Disease ◽  
Hypovitaminosis D ◽  
Alcoholic Fatty Liver ◽  
Vitamin D Levels ◽  
The Mean ◽  
Alcoholic Fatty Liver Disease

Abstract. Some epidemiological evidence suggests an inverse correlation between non-alcoholic fatty liver disease (NAFLD) frequency and vitamin D levels. Likewise, a beneficial effect of vitamin D on diabetes mellitus (DM) and insulin resistance has been observed, but this is an unsolved issue. Thus, we aimed to investigate the prevalence of hypovitaminosis D in a NAFLD Brazilian population and its association with disease severity and presence of comorbidities. In a cross-sectional study, the clinical, biochemical and histological parameters of 139 NAFLD patients were evaluated according to two different cut-off points of serum 25-hydroxyvitamin D levels (20 ng/mL and 30 ng/mL). The mean age of the population was 56 ± 16 years, most patients were female (83%), 72% had hypertension, 88% dyslipidemia, 46% DM, 98% central obesity, and 82% metabolic syndrome. Serum vitamin D levels were < 30 ng/mL in 78% of the patients, and < 20 ng/mL in 35%. The mean vitamin D level was 24.3 ± 6.8 ng/mL. The comparison between the clinical, biochemical and histological characteristics of the patients according to the levels of vitamin D showed no significant difference. Most patients with NAFLD had hypovitaminosis D, but low vitamin D levels were not related to disease severity and the presence of comorbidities.

scholarly journals The psychotropic effect of vitamin D supplementation on schizophrenia symptoms

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Aras Neriman ◽  
Yilmaz Hakan ◽  
Ucuncu Ozge
Keyword(s):  
Vitamin D ◽  
Negative Symptoms ◽  
Metabolic Diseases ◽  
Wisconsin Card Sorting Test ◽  
Sunlight Exposure ◽  
Antipsychotic Treatment ◽  
Serum 25Ohd ◽  
Vitamin D Receptors ◽  
Vitamin D Levels ◽  
The Mean

Abstract Background Schizophrenia is a multifactorial disease involving interactions between genetic and environmental factors. Vitamin D has recently been linked to many metabolic diseases and schizophrenia. Vitamin D plays essential roles in the brain in the context of neuroplasticity, neurotransmitter biosynthesis, neuroprotection, and neurotransmission. Vitamin D receptors are demonstrated in most brain regions that are related to schizophrenia. However, very few studies in the literature examine the effects of 25-hydroxyvitamin D (25OHD) on schizophrenia symptoms. Methods This study aimed to examine the effects of vitamin D replacement on positive, negative, and cognitive symptoms of schizophrenia. Serum 25OHD levels of 52 schizophrenia patients were measured. SANS and SAPS were used to evaluate the severity of schizophrenia symptoms, and the Wisconsin Card Sorting Test: CV4 was used for cognitive assessment. The study was completed with 40 patients for various reasons. The patients whose serum 25OHD reached optimal levels after vitamin D replacement were reevaluated with the same scales in terms of symptom severity. The SPSS 25 package program was used for statistical analysis. The Independent-Samples t-test was used to examine the relationship between the variables that may affect vitamin D levels and the vitamin D level and to examine whether vitamin D levels had an initial effect on the scale scores. Results The mean plasma 25OHD levels of the patients was 17.87 ± 5.54. A statistically significant relationship was found only between the duration of sunlight exposure and 25 OHD level (p < 0.05). The mean SANS and SAPS scores of the participants after 25OHD replacement (23.60 ± 15.51 and 7.78 ± 8.84, respectively) were statistically significantly lower than mean SANS and SAPS scores before replacement (51.45 ± 17.96 and 18.58 ± 15.59, respectively) (p < 0.001 for all). Only the total attention score was significantly improved after replacement (p < 0.05). Conclusion The data obtained from our study suggest that eliminating the 25OHD deficiency together with antipsychotic treatment can improve the total attention span and positive and negative symptoms in schizophrenia. The 25OHD levels should be regularly measured, replacement should be started when necessary, and the patients should be encouraged to get sunlight exposure to keep optimal 25OHD levels.

scholarly journals Physical Activity, Measures of Obesity, and Cardiometabolic Risk: The Multi-Ethnic Study of Atherosclerosis (MESA)

2014 ◽  
Vol 11 (4) ◽  
pp. 831-837 ◽  
Author(s):  
Paul A. McAuley ◽  
Haiying Chen ◽  
Duck-chul Lee ◽  
Enrique Garcia Artero ◽  
David A. Bluemke ◽  
...  
Keyword(s):  
Physical Activity ◽  
Insulin Resistance ◽  
Waist Circumference ◽  
Impaired Fasting Glucose ◽  
Central Obesity ◽  
Cardiometabolic Risk ◽  
Fasting Glucose ◽  
Reference Group ◽  
Model Assessment ◽  
Ethnic Study

Background:The influence of higher physical activity on the relationship between adiposity and cardiometabolic risk is not completely understood.Methods:Between 2000–2002, data were collected on 6795 Multi-Ethnic Study of Atherosclerosis (MESA) participants. Self-reported intentional physical activity in the lowest quartile (0–105 MET-minutes/week) was categorized as inactive and the upper three quartiles (123–37,260 MET-minutes/week) as active. Associations of body mass index (BMI) and waist circumference categories, stratified by physical activity status (inactive or active) with cardiometabolic risk factors (dyslipidemia, hypertension, upper quartile of homeostasis model assessment of insulin resistance [HOMA-IR] for population, and impaired fasting glucose or diabetes) were assessed using logistic regression analysis adjusting for age, gender, race/ethnicity, and current smoking.Results:Among obese participants, those who were physically active had reduced odds of insulin resistance (47% lower; P < .001) and impaired fasting glucose/diabetes (23% lower; P = .04). These associations were weaker for central obesity. However, among participants with a normal waist circumference, those who were inactive were 63% more likely to have insulin resistance (OR [95% CI] 1.63 [1.24–2.15]) compared with the active reference group.Conclusions:Physical activity was inversely related to the cardiometabolic risk associated with obesity and central obesity.

scholarly journals No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South

2017 ◽  
Vol 75 (1) ◽  
pp. 3-8 ◽  
Author(s):  
Yara Dadalti Fragoso ◽  
Tarso Adoni ◽  
Soniza Vieira Alves-Leon ◽  
Samira L. Apostolos-Pereira ◽  
Walter Oleschko Arruda ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Vitamin D ◽  
Large Population ◽  
Serum Vitamin ◽  
Serum Levels ◽  
Serum Vitamin D ◽  
Control Subjects ◽  
Vitamin D Levels ◽  
The Mean ◽  
25 Oh Vitamin D

ABSTRACT Objective: Vitamin D has taken center stage in research and treatment of multiple sclerosis (MS). The objective of the present study was to assess the serum vitamin D levels of a large population of patients with MS and controls living in a restricted tropical area. Methods: Data from 535 patients with MS and 350 control subjects were obtained from 14 cities around the Tropic of Capricorn. Results: The mean serum 25-OH vitamin D level was 26.07 ± 10.27 ng/mL for the control subjects, and 28.03 ± 12.19 ng/mL for patients with MS. No correlation was observed between vitamin D levels and the disability of patients over the disease duration. Conclusion: At least for the region around the Tropic of Capricorn, serum levels of vitamin D typically are within the range of 20 to 30 ng/mL for controls and patients with MS.

To screen or not to screen? Vitamin D deficiency in chronic mental illness

2017 ◽  
Vol 26 (1) ◽  
pp. 56-59
Author(s):  
Ivana Goluza ◽  
Jay Borchard ◽  
Nalin Wijesinghe ◽  
Kishan Wijesinghe ◽  
Nagesh Pai
Keyword(s):  
Vitamin D ◽  
Length Of Stay ◽  
P Value ◽  
Hydroxyvitamin D ◽  
Psychiatric Setting ◽  
Retrospective Audit ◽  
Vitamin D Levels ◽  
Significant Difference ◽  
25 Hydroxyvitamin D ◽  
The Mean

Objectives: The objective of the current study was to examine the pathology test utilisation of 25-hydroxyvitamin D (25(OH)D) within an Australian inpatient psychiatric setting. Method: A retrospective audit of 300 random hospital files of those admitted as inpatients between Nov 2014 and Nov 2015 was undertaken. Data was quantitatively analysed and described. Results: The number of inpatients who had a vitamin D determination during their admission was 37/300 (12.33%). The mean vitamin D level of those tested was 51.63 nmol/l. Of those that were tested, 18/37 (48.6%) were mildly to moderately deficient. There was a statistically significant difference in age and length of stay between those that were and were not tested for vitamin D levels, p-value <0.001 and 0.017, respectively. In addition, a simple linear regression indicated a weak association between length of stay and vitamin D levels. Conclusion: This audit highlights vitamin D screening inadequacy. More research is recommended to establish tangible benefits of supplementation, while local practice provides valuable data for education and policy purposes.

scholarly journals Association of Plasma Vitamin D Levels with Adiposity in Hispanic and African Americans

2009 ◽  
Vol 94 (9) ◽  
pp. 3306-3313 ◽  
Author(s):  
Kendra A. Young ◽  
Corinne D. Engelman ◽  
Carl D. Langefeld ◽  
Kristen G. Hairston ◽  
Steven M. Haffner ◽  
...  
Keyword(s):  
Vitamin D ◽  
African Americans ◽  
Plasma Vitamin ◽  
Vitamin D Levels

scholarly journals Body Fat Percentage, Waist Circumference and Body Mass Index are Correlated with Nitric Oxide Levels in Young Adults with Central Obesity

2021 ◽  
Vol 5 (1) ◽  
pp. 1
Author(s):  
Feriyandi Nauli ◽  
Nurhasanah Nurhasanah ◽  
Endang Mahati ◽  
Udin Bahrudin
Keyword(s):  
Nitric Oxide ◽  
Body Mass Index ◽  
Young Adults ◽  
Waist Circumference ◽  
Body Mass ◽  
Body Fat ◽  
Central Obesity ◽  
Subcutaneous Fat ◽  
Body Fat Percentage ◽  
Fat Percentage

Background: Central obesity stands for the corner-stone of cardio-metabolic health, while nitric oxide (NO) is a major regulator of cardiovascular function. To day, the correlation between serum NO metabolites nitrate/nitrite and the obesity components in young adults remains elusive. Thus, this current study was conducted to know the correlation between serum NO metabolites levels and body fat percentage, waist circumference (WC) as well as body mass index (BMI) in young adults with central obesity.Materials and Methods: A cross-sectional study was conducted in Riau, Indonesia, involving 79 young adults aged 18-25 years, composing of 39 and 40 subjects with and without central obesity, respectively. Anthropometric measurements were performed to assess WC and BMI. Body fat percentage was measured using bioelectrical impedance analysis and serum NO metabolites levels were assessed using Griess methods.Results: Levels of serum NO metabolites were significant higher in the subjects with central obesity (168.41±12.64 μmol/L) than that of normal subjects (70.57±44.99 μmol/L, p<0.001), but the levels were no significant different between male and female subjects. Serum NO metabolites levels were strongly correlated with total body fat (r=0.618, p<0.001), visceral fat (r=0.733, p<0.001), subcutaneous fat (r=0.547, p<0.001), WC (r=0.717, p<0.001) and BMI (r=0.788, p<0.001).Conclusions: For young adults in Riau, Indonesia, levels of serum NO metabolites are higher in the central obesity group than that of the normal. In this population, body fat percentage, waist circumference and body mass index are correlated with serum nitric oxide metabolites levels.Keywords: nitric oxide, body fat percentage, young adults, central obesity

scholarly journals Correlation of Serum Vitamin D and Metabolic Disturbances in Polycystic Ovarian Syndrome

2021 ◽  
Vol 4 (1) ◽  
pp. 64-71
Author(s):  
Shasya Aniza Santoso ◽  
◽  
Tita Husnitawati Madjid ◽  
Anita Rachmawati
Keyword(s):  
Insulin Resistance ◽  
Vitamin D ◽  
Blood Glucose ◽  
Waist Circumference ◽  
Fasting Blood Glucose ◽  
Serum Vitamin ◽  
Metabolic Disturbances ◽  
Cross Sectional ◽  
Serum Vitamin D ◽  
Vitamin D Levels

Objective: This study was aimed to determine the correlation between vitamin D and insulin resistance in women with PCOS. Method: This study was correlational analytic with cross-sectional approach to 34 women diagnosed with PCOS based on ultrasonography. Waist circumference and fasting blood glucose (FBG) represented insulin resistance. Women with hormonal therapy and vitamin D supplementation were not included to this study. This study used consecutive sampling method. Result: The average of age was 25.6±6.1 years old. Waist circumference and fasting blood glucose (FBG) represented insulin resistance. The average of waist circumference and FBG were 87.6±12.4 cm and 86.2±27.9 mg/dl, respectively. The mean of vitamin D levels was 11,5±3,6 ng/ml. According to Spearman’s correlation, vitamin D levels were weak negative correlated with waist circumference (r=-0.2; p>0.05) and FBG (r= -0,1; p>0,05), it statistically was not significant. Conclusion: There is weak negative correlation between vitamin D and metabolic syndrome in PCOS patients.

Sign in / Sign up

Export Citation Format

Share Document